EFFECTIVENESS AND SAFETY OF CONCOMITANT USE OF PEPTIDE COMPLEX AND DIACEREIN IN OSTEOARTHRITIS OF KNEE JOINT
Эффективность и безопасность совместного применения пептидного комплекса и диацереина при остеоартрите коленного сустава
2022-01-01
SCID: 54.1/vd8jbwcr
Discuss with AI
SYSADOAWOMAC indexdiacereinglycosaminoglycan peptide complexknee osteoarthritis
Figures from the paper
Abstract (AI)
As part of a prospective study, it was evaluated the efficacy and safety of the combined use of drugs from the group of symptomatic slow acting agents (SYSADOA): Diacerein and glycosaminoglycan peptide complex (GPC) in patients with knee osteoarthritis. The dynamics of pain according to Visual Analoguе Scale (VAS), need for non-steroidal anti-inflammatory drugs, the WOMAC index, EQ-5D score, and OMERACT-OARSI criterion, the presence of adverse events were analyzed, and the effect of Diacerein on the components of the metabolic syndrome was assessed. It was shown that the concomitant use of GPC and Diacerein demonstrated high efficiency and equivalent safety in comparison with the isolated use of GPC: a decrease in the pain intensity in the early stages of therapy, a decrease in the need for NSAIDs, a tendency to improve lipid and purine metabolism.
Key Findings
1
A prospective study evaluated concomitant glycosaminoglycan peptide complex and diacerein for knee osteoarthritis, assessing efficacy, safety, symptoms, quality of life, and metabolic effects.
2
Combination treatment decreased patients’ need for nonsteroidal anti-inflammatory drugs compared with baseline.
3
Combined glycosaminoglycan peptide complex and diacerein reduced pain intensity during the early stages of therapy.
4
Concomitant therapy demonstrated high efficacy and safety equivalent to glycosaminoglycan peptide complex used alone.
5
Diacerein showed a tendency to improve lipid and purine metabolism components associated with metabolic syndrome.
Research Object
Patients with knee osteoarthritis receiving concomitant glycosaminoglycan peptide complex and diacerein therapy
Research Subject
The efficacy and safety of concomitant therapy, including effects on pain, NSAID use, functional and quality-of-life measures, adverse events, and metabolic-syndrome components
Publication Details
Publication Date
2022-01-01
Journal
Publisher
ISSN
Cited by
0
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal2024
An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)2019
Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis2019